These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 17160057)

  • 1. Where have all the antibiotic patents gone?
    Katz ML; Mueller LV; Polyakov M; Weinstock SF
    Nat Biotechnol; 2006 Dec; 24(12):1529-31. PubMed ID: 17160057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ownership of knowledge--the role of patents in pharmaceutical R&D.
    Correa CM
    Bull World Health Organ; 2004 Oct; 82(10):784-7; discussion 787-90. PubMed ID: 15643801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Merck v. Integra: Supreme Court permits use of patented compounds to obtain Food and Drug Administration approvals.
    Manthei JR; Hathaway CR; Grant MA; Chung DD
    Food Drug Law J; 2006; 61(2):273-7. PubMed ID: 16903032
    [No Abstract]   [Full Text] [Related]  

  • 4. Are the economics of pharmaceutical research and development changing?: productivity, patents and political pressures.
    Grabowski H
    Pharmacoeconomics; 2004; 22(2 Suppl 2):15-24. PubMed ID: 15660474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming the obstacles in the pharma/biotech industry: 2008 update.
    Graul AI; Revel L; Rosa E; Cruces E
    Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Societal costs versus savings from wild-card patent extension legislation to spur critically needed antibiotic development.
    Spellberg B; Miller LG; Kuo MN; Bradley J; Scheld WM; Edwards JE
    Infection; 2007 Jun; 35(3):167-74. PubMed ID: 17565458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Realizing two-tiered innovation policy through drug regulation.
    Ridgway WE
    Stanford Law Rev; 2006 Feb; 58(4):1221-50. PubMed ID: 16685807
    [No Abstract]   [Full Text] [Related]  

  • 8. Does R&D pay?
    Cavalla D; Minhas R
    Drug Discov Today; 2010 Mar; 15(5-6):230-4. PubMed ID: 19931643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brand-name drug companies fail to meet R&D commitments.
    Kondro W
    CMAJ; 2006 Aug; 175(4):344. PubMed ID: 16908891
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of the impact of the Uruguay Round Agreements Act on pharmaceutical patents.
    Seoane-Vazquez E; Rodriguez-Monguio R; Szeinbach SL; Beyer A; Visaria J
    Food Drug Law J; 2009; 64(1):171-81. PubMed ID: 19998745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short patent lives jeopardize drug and patient safety.
    Hondeghem LM; De Clerck F; Camm J
    J Cardiovasc Pharmacol; 2007 Oct; 50(4):353-7. PubMed ID: 18049301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compulsory licensing to regulated licensing: effects on the conflict between innovation and access in the pharmaceutical industry.
    Gillat A
    Food Drug Law J; 2003; 58(4):711-40. PubMed ID: 15027457
    [No Abstract]   [Full Text] [Related]  

  • 13. A new approach to drug development.
    Brown S
    N Engl J Med; 2006 Nov; 355(19):2045; author reply 2046. PubMed ID: 17099948
    [No Abstract]   [Full Text] [Related]  

  • 14. The shifting functional balance of patents and drug regulation.
    Eisenberg RS
    Health Aff (Millwood); 2001; 20(5):119-35. PubMed ID: 11558697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary patents in the pharmaceutical industry: missing the wood for the trees?
    Kiran S; Kulkarni M
    Expert Opin Ther Pat; 2018 Mar; 28(3):241-250. PubMed ID: 29298119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Promising Viral Threat to Bacterial Resistance: the Uncertain Patentability of Phage Therapeutics and the Necessity of Alternative Incentives.
    Todd K
    Duke Law J; 2019 Jan; 68(4):767-805. PubMed ID: 30649837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. India's patent ecosystem - encouraging strong patents or discouraging innovation?
    Harrison C
    Nat Rev Drug Discov; 2013 Oct; 12(10):732-3. PubMed ID: 24080690
    [No Abstract]   [Full Text] [Related]  

  • 18. EU court gets tough on patent extensions for combo products.
    Waters H
    Nat Med; 2012 Jan; 18(1):4. PubMed ID: 22227647
    [No Abstract]   [Full Text] [Related]  

  • 19. EC fines AstraZeneca in Losec antitrust case.
    Owens J
    Nat Rev Drug Discov; 2005 Jul; 4(7):530. PubMed ID: 16078374
    [No Abstract]   [Full Text] [Related]  

  • 20. Patent watch: post-approval testing shielded from patent infringement.
    Harrison C
    Nat Rev Drug Discov; 2012 Sep; 11(9):666. PubMed ID: 23097768
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.